Introdução: O comprometimento cognitivo na doença renal crônica (DRC) é comumente associado a distúrbios neuropsiquiátricos. Sendo uma patologia complexa, a DRC, em qualquer estágio, requer que o paciente tenha uma boa compreensão da necessidade de adesão ao medicamento e à nutrição. A triagem cognitiva é o ponto de partida para a detecção de deficiências cognitivas. Objetivo: Determinar a especificidade e a sensibilidade da versão em português do Brasil do Montreal Cognitive Assessment -Basic (MoCA-B) para identificação de comprometimento cognitivo na população com DRC. Métodos: Este foi um estudo transversal com 163 pacientes com DRC em tratamento hemodialítico. Foram aplicados o Mini Exame do Estado Mental (MEEM) e o MoCA-B. Resultados: O MoCA-B obteve consistência interna confiável (alfa de Cronbach = 0,74). Um ponto de corte de ≤ 21 pontos fornece a melhor sensibilidade e especificidade para a detecção de comprometimento cognitivo. A variável educação teve menos impacto no escore total do MoCA-B do que no escore total do MEEM. Conclusões: O MoCA-B é um instrumento de triagem adequado para avaliar a cognição global de pacientes em hemodiálise. Os resultados podem ajudar os profissionais de saúde a realizar avaliações e planejar o manejo clínico. Descritores: Testes de estado mental e demência, psicometria, doença renal, testes neuropsicológicos.
Introduction
Cognitive impairment in chronic kidney disease (CKD) is commonly associated with neuropsychiatric disorders such as depression, delirium, and dementia. 1 It is believed that identification of cognitive deficits in chronic patients may have a positive impact on the prognosis of treatment. Timely intervention can modify the course of the disease, 2 since a patient with cognitive impairment may have poor adherence to medication and treatment, and may have malnutrition, reduced quality of life, increased care costs, and early mortality. 3 Chronic kidney disease is a complex pathology and so at all stages patients must understand the need for adherence to drug prescriptions and nutritional advice.
Although cognitive impairment among these patients is recognized in the literature, it is underdiagnosed in the clinical context and is often perceived as resistance to therapeutic adherence. While no medical intervention currently available can reverse the progression of dementia-related degenerative disorders, it is believed that early identification of cognitive decline may modify the impact of these disorders on cognition and on patient's lack of autonomy. 2 Cognitive screening is the starting point for detection of cognitive impairments, dementia, and other neuropsychiatric syndromes, constituting an important public and clinical health initiative. A relatively small number of short cognitive screening instruments are used by most clinicians and in some cases their efficacy is unknown. 4 The Montreal Cognitive Assessment -Basic (MoCA-B) was created with the objective of testing people who were illiterate or had less than five years of schooling. 7 The Brazilian version was adapted by Daniel Apolinario and is available on mocatest.org. Due to the predominance of low schooling among renal patients in Brazil, this instrument may be more appropriate for administration in this context. There is recent interest in the literature in identifying cut-off criteria for different populations. 8, 9 However, there are no published studies 
Method
This is a cross-sectional study approved by the health ethics committee at the Universidade Federal do Paraná, Brazil (CAAE: 69700717.7.0000.0102). All participants signed the informed consent form before participating.
The participants who administrate the tests were trained in the same way by the main researchers. They had had no contact with demographic and health information prior to administrating the survey.
Participants
The study sample consisted of 163 patients with Chronic Renal Disease, recruited by convenience and assessed between January and August of 2018. Patients who met the eligibility criteria were actively enrolled at any of three selected hemodialysis clinics in the city of Curitiba, PR, Brazil. The eligibility criteria were: age over 18 years; and absence of any significant hearing or visual impairments that would prevent administration of the cognitive assessment tool.
Instruments
Three instruments were used for evaluation of participants, as described below.
Sociodemographic questionnaire
An instrument covering identification information 
Mini-Mental State Examination (MMSE)
This was used as a gold standard measure for identification of cognitive impairment. An adaptation by Duncan et al. was used. 10 
Montreal Cognitive Assessment -Basic (MoCA-B)
This is a 30-point test that evaluates six cognitive domains: visual perception, executive functioning, language, attention, memory, and orientation. 7 The
Brazilian Portuguese version was adapted by Daniel
Apolinario and is freely available for clinical use (www. mocatest.org, see the Basic section). The English language version of the test considers a score < 24 as identifying cognitive impairment. There are no studies of the Brazilian Portuguese version that indicate a score for reference.
Data analysis
Descriptive analysis of the data was performed 
Results
All participants in the sample were at chronic renal disease stage 5, with glomerular filtration rate (GFR) of 15 ml/min or less, and were on hemodialysis. Table 1 shows the sociodemographic and clinical characteristics Table 3 shows the performance Table 5 presents the sensitivity and specificity of the instrument according to the cutoff criteria analyzed.
With a cutoff score of < 21, the instrument achieved 77.46% sensitivity and 72.83% specificity. Figure 1 shows the ROC curve plotted to determine the best sensitivity and specificity for MoCA-B.
Using the MoCA-B to detect cognitive impairment with a cutoff of ≤ 21 showed better results than chance (AUC = 0.777, p < 0.001, Youden index = 0.503). 
Discussion
The aim of this study was to determine the specificity and sensitivity of the Brazilian Portuguese version of the MoCA-B in a population with Chronic Kidney Disease.
The results showed that the cutoff criterion ≤ 21 had Using this criterion, we obtained sensitivity of 87.32%
and specificity of 46.74%. It was found that the cutoff score of ≤ 21, proposed by this study, provides more accurate results than the original study.
Other studies of international versions that The present study identified that the variable education had less impact on the total score of the MoCA-B than on the total score of the MMSE. Considering that the purpose of the instrument is to evaluate populations with low educational level, it is adequate for evaluation of the Brazilian population with CKD. Several studies suggest that schooling is low among CKD patients and it is estimated that the majority did not finish elementary school. 15, 16 Ardila 17 reports that the influence of educational variables on the performance of neuropsychological tests is well established, demonstrated both in individuals without pathologies and also in populations with brain damage.
However, the educational effect is not linear, it represents a negatively accelerated curve, tending to a threshold, since the ceiling in neuropsychological tests is usually low.
This author reports that the differences between 0 and 3 years of education are highly significant, but differences decrease as years of study increase, and the tendency is not to find differences between, for example, 12 and 
